PEDIATRIC SURGERY UPDATE ©
VOLUME 03, 1994
VOLUME 03 NO 01 JULY 1994
Bile-Plug Syndrome
Define as a partial or complete intraluminal obstruction of the extrahepatic
bile ducts caused by an abnormal, viscous, inspissated bile. Clinical presentation
is that persistent (conjugated) jaundice. This condition is associated
to: massive hemolysis from Rh or ABO incompatibility, cystic fibrosis,
TPN, and ileal resections. Ultrasound findings are: dilated gallbladder
with sludge or stone formation, dilated common bile duct with sludge (echogenic
appearance), and no acoustic shadowing. DISIDA shows no intestinal excretion
of the radioisotope. Most cases subside spontaneously. Those associated
to worsening of direct hyperbilirubinemia and liver function tests should
be managed surgically. Irrigation of bile ducts with saline or N- acetylcysteine
through the gallbladder is curative.
References
1- Lang EV, Pinckney LE: Spontaneous resolution of bile-plug
syndrome. AJR Am J Roentgenol 156(6):1225-6, 1991
2- Brown DM: Bile plug syndrome: successful management
with a mucolytic agent. J Pediatr Surg 25(3):351-2, 1990
3- Mahr MA, Hugosson C, Nazer HM, Saad SA, Ali MA: Bile-plug
syndrome. Pediatr Radiol 19(1):61-4, 1988
4- Pfeiffer WR, Robinson LH, Balsara VJ: Sonographic
features of bile plug syndrome. J Ultrasound Med 5(3):161-3, 1986
Gallstones
With the increase use of sonography in the work-up of abdominal pain, cholelithiasis
is diagnosed more frequently in children. Gallstones occur as consequence
of loss of solubility of bile constituents. Two types are recognize: cholesterol
and bilirubin. Those of cholesterol are caused by supersaturation of bile
(lithogenic) by cholesterol overproduction or bile salt deficiency. Bilirubin
stones occur due to hemolysis (Sickle Cell, thalassemia) or bacterial infection
of bile. Other etiologies include: Ascaris Lumbricoides infestation, drug-induced
(ceftriaxone), ileal resection, TPN. etc. Gallbladder sludge is a clinical
entity that when it persists can be a predisposing factor for cholelithiasis
and cholecystitis. Management of symptomatic gallstones consists of laparoscopic
cholecystectomy which has found to: reduce hospital stay, increase child
return to normal activities, is well tolerated, low complication rate,
but increases cost of procedure.
References
1- Riccabona M, Kerbl R, Schwinger W, Spork D, Millner
M, Grubbauer HM: [Ceftriaxone-induced cholelithiasis--a harmless side-effect?]Klin
Padiatr 205(6):421-3, 1993
2- Gerry F, Jaby O, Forbin C, Ebrad P: [Surgical treatment
of cholelithiasis in children with sickle-cell anemia] Pediatrie (Bucur)
46(2):209-12, 1991
3- Schulman A: Intrahepatic biliary stones: imaging features
and a possible relationship with ascaris lumbricoides. Clin Radiol 47(5):325-32,
1993
4- Bhattacharyya N, Wayne AS, Kevy SV, Shamberger RC:
Perioperative management for cholecystectomy in sickle cell disease. J
Pediatr Surg 28(1):72-5, 1993
5- Ware RE, Kinney TR, Casey JR, Pappas TN, Meyers WC:
Laparoscopic cholecystectomy in young patients with sickle hemoglobinopathies.
J Pediatr 120(1):58-61, 1992
6- Heubi JE, O'Connell NC, Setchell KD: Ileal resection/dysfunction
in childhood predisposes to lithogenic bile only after puberty. Gastroenterology
103(2):636-40, 1992
7- Erdamar I, Avci G, Fuzun M, Harmancioglu O: Extracorporeal
shockwave lithotripsy and litholytic therapy in cholelithiasis. Br J Surg
79(3):235-6, 1992
8- Reif S, Sloven DG, Lebenthal E: Gallstones in
children. Characterization by age, etiology, andoutcome [see comments]
Am J Dis Child 145(1):105-8, 1991
On HD Etiology
Hirschsprung's disease (HD) is characterized by lack of enteric ganglion
cells, hyperplasia of abnormal nerve fibers and a non- propulsive, non-relaxing
segment of bowel. Classically the etiology is attributed to a failure of
cranio-caudal migration of parasympathetic neural crest cells to the distal
bowel. A plausible explanation for the failure of relaxation of the bowel
involved is a deficiency of enteric inhibitory nerves that mediates the
relaxation phase of peristalsis. This nerves are intrinsic to the gut and
are classify as non-adrenergic and non-cholinergic. Nitric oxide (NO) has
recently been implicated as the neurotransmitter which mediates the relaxation
of smooth muscle of the GI tract in HD. It's absence in aganglionic bowel
might account for the failure of relaxation during peristalsis. Besides
adhesions molecules (absent in aganglionic bowel) during early embryogenesis
might restrict the neuro-ectodermal origin involved in the initial contact
between nerves and muscle cell (synaptogenesis) suggesting that developmental
anomaly of innervated muscle and absent NO causes the spasticity characteristic
of HD.
References
1- Whalen TV Jr, Asch MJ: Report of two patients with
hypertrophic pyloric stenosis and Hirschsprung's disease. Coincident or
common etiology? Am Surg 51(8):480-1, 1985
2- Passarge E: The genetics of Hirschsprung's disease.
Evidence for heterogeneous etiology and a study of sixty-three families.
N Engl J Med 276(3):138-43, 1967
3- Tam PK, Quint WG, van Velzen D: Hirschsprung's disease:
a viral etiology? Pediatr Pathol 12(6):807-10, 1992
CF Prenatal Diagnosis
Cystic Fibrosis is an autosomal recessive lethal disease affecting 1 in
2000 live newborns. Is caused by different mutations in the cystic fibrosis
transmembrane conductance (CFTC) regulator gene. Prenatal diagnosis is
possible to couples of carriers with a one- fourth risk of having an affected
newborn. Reliability of the test is 98%. The sample is taken as chorionic
villus (10-14 week gestation) or amniocentesis. A DNA polymerase chain
reaction analysis has shown a major mutation in the delta F508 position
(is a three base pair deletion in exon 10 which results in a protein without
the amino acid phenylalanine at position 508) of the long arm of chromosome
7.
References
1- DeMarchi JM, Beaudet AL, Caskey CT, Richards CS: Experience
of an academic reference laboratory using automation for analysis of cystic
fibrosis mutations. Arch Pathol Lab Med 118(1):26-32, 1994
2- Mennie M, Compton M, Gilfillan A, Axton RA, Liston
WA, Pullen I, Whyte D, Brock DJ: Prenatal screening for cystic fibrosis:
attitudes and responses of participants. Clin Genet 44(2):102-6, 1993
3- Ferec C, Verlingue C, Audrezet MP, Guillermit H, Quere
I, Raguenes O, Mercier B: Prenatal diagnosis of cystic fibrosis in different
European populations: application of denaturing gradient gel electrophoresis.
Fetal Diagn Ther 8(5):341-50, 1993
4- Denayer L, Evers-Kiebooms G, De Boeck K, Van den Berghe
H: Reproductive decision making of aunts and uncles of a child with cystic
fibrosis: genetic risk perception and attitudes toward carrier identification
and prenatal diagnosis. Am J Med Genet 44(1):104-11, 1992
5- Mennie ME, Gilfillan A, Compton M, Curtis L, Liston
WA, Pullen I, Whyte DA, Brock DJ: Prenatal screening for cystic fibrosis.
Lancet 340(8813):214-6, 1992
VOL 03 NO 02 AUGUST 1994
Intestinal Neuronal Dysplasia
Intestinal Neuronal Dysplasia (IND) is a colonic motility disorder first
described in 1971 by Meier-Ruge associated to characteristic histochemical
changes of the bowel wall (hyperplasia of submucous & myenteric plexus
with giant ganglia formation, isolated ganglion cells in lamina propia
and muscularis mucosa, elevation of acetylcholinesterase in parasympathetic
fiber of lamina propia and circular muscle, and myenteric plexus sympathetic
hypoplastic innervation),also known as hyperganglionosis associated to
elevated acetylcholinesterase parasympathetic staining. The condition can
occur in an isolated form (either localized to colon or disseminated throughout
the bowel), or associated to other diseases such as Hirschsprung's (HD),
neurofibromatosis, MEN type IIB, and anorectal malformations. It is estimated
that 20-75% of HD cases have IND changes proximal to the aganglionic segment.
Clinically two different types of isolated IND have been described: Type
A shows symptoms of abdominal distension, enterocolitis, bloody stools,
intestinal spasticity in imaging studies (Ba Enema) since birth, is less
common and associated with hypoplasia of sympathetic nerves. Type B is
more frequent, symptoms are indistinguishable from that of HD, with chronic
constipation, megacolon, and repeated episodes of bowel obstruction. Management
depends on clinical situation; conservative for minor symptoms until neuronal
maturation occurs around the 4th year of life, colostomy and resectional
therapy for life threatening situations.
References
1- Lugo-Vicente HL: Neuronal Intestinal Dysplasia: A Role
for Surgery? Boletin Asoc Med PR 87(3-4): 60-63,1995
Prenatal Cystic Hygroma
Cystic hygroma (CH) is an uncommon congenital lesion of the lymphatic system
appearing as a multilocular fluid filled cavity most commonly in the back
neck region, occasionally associated with extensive involvement of airway
or vital structures. The etiology is intrauterine failure of lymphatics
to communicate with the venous system. Prenatal diagnosis can be done during
the first trimester of pregnancy as a huge neck tumor. Differential diagnosis
includes teratomas, encephalocele, hemangiomas, etc. There is a strong
correlation between prenatal dx and Turner's syndrome (> 50%), structural
defects (Noonan's syndrome) and chromosomic anomalies (13, 18, 21). Early
diagnosis (< 30 wk gestation) is commonly associated to those anomalies,
non-immune hydrops and dismal outcome (fetal death). Spontaneous regression
is less likely but can explain webbed neck of Turner and Noonan's children.
Prenatal dx should be followed by cytogenetic analysis: chorionic villous
sampling, amniocentesis, or nuchal fluid cell obtained from the CH itself
to determine fetal karyotype and provide counseling of pregnancy. Late
diagnosis (>30 wks) should be delivered in tertiary center prepare to deal
with dystocia and postnatal dyspnea of newborn. The airway should be secured
before cord clamping in huge lesions.
References
1- Anderson NG, Kennedy JC: Prognosis in fetal cystic
hygroma. Aust N Z J Obstet Gynaecol 32(1):36-9, 1992
2- Iloki LH, Azika ME, Bouramoue V:[Prenatal diagnosis
of cystic hygroma of the neck by echography. Case report. Review of the
literature] Rev Fr Gynecol Obstet 87(1):42-4, 1992
3- Bernard P, Chabaud JJ, Le Guern H, Le Bris MJ, Boog
G:[Cystic hygroma of the neck. Antenatal diagnosis, prognostic factors,
management. 42 cases] J Gynecol Obstet Biol Reprod (Paris) 20(4):487-95,
1991
4- Pijpers L, Reuss A, Stewart PA, Wladimiroff JW, Sachs
ES: Fetal cystic hygroma: prenatal diagnosis and management. Obstet Gynecol
72(2):223-4, 1988
5- Cohen MM, Schwartz S, Schwartz MF, Blitzer MG, Raffel
LJ, Mullins-Keene CL, Sun CC, Blakemore KJ: Antenatal detection of cystic
hygroma. Obstet Gynecol Surv 44(6):481-90, 1989
6- Abramowicz JS, Warsof SL, Doyle DL, Smith D, Levy DL:
Congenital cystic hygroma of the neck diagnosed prenatally: outcome with
normal and abnormal karyotype. Prenat Diagn 9(5):321-7, 1989
GER and RS
Although a fundoplication is effective in controlling gastroesophageal
reflux (GER), it could be less effective in curing respiratory symptoms
(RS) such as aspiration, apnea, choking, chronic cough and wheezing attributed
to reflux in children. The problem is documenting a cause-effect relationship
between GER and RS. Objective parameters used are the ZMD (mean duration
of reflux episodes during sleep by 18-24 hr ph-study), isotopic tracing
in lung during milk scintigrams and sx preceded by a drop in ph. A ZMD
> 4 min can be a reliable preop sign the antireflux surgery will cure the
RS. Reversible obstructive airway disease pts. are more prone to suffer
from GER secondary to RS with less chances of being relieved by fundoplication.
Neurologically impaired child with RS has highest rate of failure. Medical
tx and transgastric jejunostomy feeding are effective for poor operative
risk pts.
References
1- Halpern LM, Jolley SG, Tunell WP, Johnson DG, Sterling
CE: The mean duration of gastroesophageal reflux during sleep as an indicator
of respiratory symptoms from gastroesophageal reflux in children. J Pediatr
Surg 26(6):686-90, 1991
2- de Blic J, Revillon Y, Scheinmann P: The relationship
between gastroesophageal reflux and chronic respiratory diseases. Clin
Rev Allergy 8(4):427-41, 1990
3- Barish CF, Wu WC, Castell DO: Respiratory complications
of gastroesophageal reflux. Arch Intern Med 145(10):1882-8, 1985
4- Orenstein SR, Orenstein DM: Gastroesophageal reflux
and respiratory disease in children [published erratum appears in J Pediatr
1988 Sep;113(3):578] J Pediatr 112(6):847-58, 1988
5- Padman R, Quijano R: Gastroesophageal reflux and recurrent/chronic
pulmonary disease in infants and children. Del Med J 61(10):547-54, 1989
VOL 03 NO 03 SEPTEMBER 1994
TPNIC
TPN induced cholestatic (TPNIC) jaundice is an uncommon conjugated hyperbilirubinemia
in infant which carries serious implications. Infectious, metabolic, and
structural causes of cholestasis should be rule-out. The incidence of TPNIC
is around 30-50% of infants receiving prolonged TPN. Very low birth weight
and prematures are more at risk than term infants. No single etiologic
factor has been identified, although large amounts of amino acids associated
to low amounts of fat in the TPN solution can cause sludge and stone formation
in the gallbladder. The most important factor in the hepato-biliary dysfunction
is the patient underlying disease state and severity of his illness. TPNIC
is a predisposing factor for sepsis in surgical neonates since it leads
to impaired non-specific cellular immunity. Cholestasis is associated with
intracranial hemorrhage, PDA, sepsis, and GI conditions requiring surgery.
This infants will show markedly elevated liver enzymes, no excretion of
Tc labeled HIDA and increased GGT levels. Liver histology correlates with
the chronologic progression of the disease process and TPN use as follows:
by 5 days of TPN you can find steatosis with prominent eosinophils in portal
tracts, by 10 days there is canalicular cholestasis, by 21 days bile duct
proliferation, by 90 days portal fibrosis and after 5 months micronodular
cirrhosis. Phenobarbital which increase bile flow has not been found beneficial
in TPNIC. In most cases the degree of dysfunction is self-limiting and
reversible upon cessation of TPN.
References
1- Horslen SP: Cholestasis in infancy: 1. Br J Hosp Med
50(11):674-7, 1993
2- Komura J, Yano H, Tanaka Y, Tsuru T: Increased incidence
of cholestasis during total parenteral nutrition in children--factors affecting
stone formation. Kurume Med J 40(1):7-11, 1993
3- Rintala R, Lindahl H, Pohjavuori M, Saxen H, Sariola
H: Surgical treatment of intractable cholestasis associated with total
parenteral nutrition in premature infants. J Pediatr Surg 28(5):716-9,
1993
4- Nousia-Arvanitakis S, Angelopoulou-Sakadami N, Metroliou
K: Complications associated with total parenteral nutrition in infants
with short bowel syndrome. Hepatogastroenterology 39(2):169-72, 1992
5- Payne-James JJ, Silk DB: Hepatobiliary dysfunction
associated with total parenteral nutrition. Dig Dis 9(2):106-24, 1991
6- Bell RL, Ferry GD, Smith EO, Shulman RJ, Christensen
BL, Labarthe DR, Wills CA: Total parenteral nutrition-related cholestasis
in infants. JPEN J Parenter Enteral Nutr 10(4):356-9, 1986
7- Merritt RJ: Cholestasis associated with total parenteral
nutrition. J Pediatr Gastroenterol Nutr 5(1):9-22, 1986
8- Lilly JR, Sokol RJ: On the bile sludge syndrome or
is total parenteral nutrition cholestasis a surgical disease? Pediatrics
76(6):992-3, 1985
GER and NI
Feeding disturbances, vomiting, anticonvulsant drug non-compliance, and
recurrent chest infections in neurologically impaired (NI) children often
request the effort of surgical options to improve growth, nutrition, quality
of life and reduce seizure activity. Options are enteral tube feeding,
percutaneous endoscopic gastrostomy (PEG), and open gastrostomy with or
without antireflux surgery (ARS). Whenever a NI child is referred for feeding
gastrostomy a expeditious search for gastroesophageal reflux (GER) is achieved
and ARS considered. ARS in NI has a higher rate of complication than in
non-NI children (4:1). They include: wrap herniation into chest (entire
or paraesophageal), disruption and recurrent preop GER symptoms (vomiting
and pneumonia are the most troublesome). The etiology of NI offers little
help in predicting success of ARS. Theories explaining this high rate of
failure are: supine position, swallowing incoordination, esophageal dysmotility,
spasticity, seizures, delayed gastric emptying, chronic constipation and
scoliosis (increase intrabdominal pressure). Not every NI child requires
ARS in the presence of GER. Improving nutrition can decrease GER symptoms.
PEG can help improve nutrition and serve as a screening tool for those
pts. with continuing GER related problems who will eventually need ARS.
Ballantine permanent roux-en-y jejunostomy is another alternative in pts.
with persistent feeding intolerance after ARS.
References
1- Pearl RH, Robie DK, Ein SH, Shandling B, Wesson DE,
Superina R, Mctaggart K, Garcia VF, O'Connor, Filler RM: Complications
of gastroesophageal antireflux surgery in neurologically impaired versus
neurologically normal children. J Pediatr Surg 25(11):1169-73, 1990
2- Reyes AL, Cash AJ, Green SH, Booth IW: Gastrooesophageal
reflux in children with cerebral palsy. Child Care Health Dev 19(2):109-18,
1993
3- Glassman MS, Dozer AJ, Newman LJ: Gastroesophageal
reflux in neurologically impaired children: perioperative evaluation and
management. South Med J 85(3):289-92, 1992
WT and HA
In 1967 hyaluronic acid (HA), a glycosaminoglycan is detected in the serum
and urine of a patient with a Wilm's Tumor (WT). HA has also been found
in children with WT to: cause serum hyperviscosity , suppress the formation
of humoral precipitating antibodies to certain major classes of proteins
(interfering with elicitation of a complete antibody response), and produce
platelet dysfunction presenting as coagulopathy suggesting Acquire von
Willebrand disease. The group from UCSF School of Medicine postulated that
since the fetal kidney is the source of circulating HA stimulating activity
and WT is an embryonal tumor, HA could serve as a WT tumor marker. A cooperative
study started in 1990 gathered data for 105 pts proved that: HA urine levels
in WT pts are high preop, decrease with tumor resection and persist high
with tumor persistence or relapse (APSA 94).
References
1- Longaker MT, Adzick NS, Harrison MR, Stern R: A new
tumor marker for Wilm's tumor called hyaluronic
acid-stimulating activity
(HASA) [letter] J Pediatr Surg 25(9):1015, 1990
2- Kumar S, West DC, Ponting JM: Hyaluronic acid and childhood
renal tumors [letter; comment] J Natl Cancer Inst 82(11):973-4, 1990
3- Longaker MT, Adzick NS, Sadigh D, Hendin B, Stair SE,
Duncan BW, Harrison MR, Spendlove R, Stern R: Hyaluronic acid-stimulating
activity in the pathophysiology of Wilms' tumors [see comments] J Natl
Cancer Inst 82(2):135-9, 1990
4- Hopwood JJ, Dorfman A: Glycosaminoglycan synthesis
by Wilms' tumor. Pediatr Res 12(1):52-6, 1978
5- Morse BS,Nussbaum M: The detection of hyaluronic acid
in the serum and urine of a patient with nephroblastoma. Am J Med 42(6):996-1002,
1967
6- American Pediatric Surgical Association (APSA) 1994
Meeting
VOL 03 NO 04 OCTOBER 1994
Acute Pancreatitis
Acute pancreatitis (AP) is unusual in the pediatric patient, can affect
all age groups and should be considered in children presenting with acute
abdominal complaints Causes are diversely and clinical course less severe.
The three most common etiological factors are: trauma, drug-induced, and
biliary tract disorders. Other factors to consider are: infections (mumps,
ascaris, adenovirus), metabolic (branched-chain organic acidemias), structural
defects (anomalous union of pancreatico-biliary ductal system), and hereditary.
Blunt abdominal trauma is the leading cause (20-30%)of AP by crushing the
fixed organ between the spine. Drugs associated to the development of AP
are: steroids, L-asparaginase, valproic acid, acetaminophen (drug withdrawal
is treatment of choice). Biliary disorders related to AP are gallstone
and choledochal cysts by causing transient ductal obstruction. Most common
complaint of children with AP is abdominal pain. Diagnosis is confirmed
with elevated amylase/lipase in serum and urine (lipase is more specific
since pancreas is major source). Imaging studies of utility are US, CT-Scan
and ERCP. The use of ERCP in previously idiopathic cases of AP have increased
the yield of diagnosing anomalous pancreatico-biliary junctional defects.
Management during early phase is supportive with IV therapy, NG decompression,
NPO (to decrease acid stimulation and prevent secretin release), and nutritional
(TPN). Surgery is rarely required except complications such as abscess
and pseudocyst formation.
References
1- Simon HK, Muehlberg A, Linakis JG: Serum amylase determinations
in pediatric patients presenting to the ED with acute abdominal pain
or trauma. Am J Emerg Med 12(3):292-5, 1994
2- Kahler SG, Sherwood WG, Woolf D, Lawless ST, Zaritsky
A, Bonham J, Taylor CJ, Clarke JT, Durie P, Leonard JV: Pancreatitis in
patients with organic acidemias. J Pediatr 124(2):239-43, 1994
3- Kozarek RA, Christie D, Barclay G: Endoscopic therapy
of pancreatitis in the pediatric population. Gastrointest Endosc 39(5):665-9,
1993
4- Mori K, Nagakawa T, Ohta T, Nakano T, Kayahara M, Akiyama
T, Kanno M, Ueno K, Konishi I, Izumi R, et al: Pancreatitis and anomalous
union of the pancreaticobiliary ductal system in childhood [see comments]
J Pediatr Surg 28(1):67-71, 1993
5- Winchester M: Pancreatitis in children. Gastroenterol
Nurs 15(3):125-8. 1992
6- Moir CR, Konzen KM, Perrault j: Surgical therapy and
long-term follow-up of childhood hereditary pancreatitis. J Pediatr Surg
27(3):282-6, 1992; discussion 286-7
7- Mader TJ, McHugh TP: Acute pancreatitis in children.
Pediatr Emerg Care 8(3):157-61, 1992
Water in Neonates
Water represents 70-80% of body weight of normal neonates and premature
babies respectively. Total body water (TBW) varies inversely with fat content
(prematures have less fat deposits). TBW is distributed into 1/3 extracellular
(ECF) and 2/3 intracellular (ICF) fluids compartments. The ECF is composed
of plasma volume (4-5% body weight), intersticial and transcellular fluids.
There is a change in body water upon entrance of the fetus to his new extrauterine
existence; A gradual decrease in TBW and ECF, and an increase in the ICF.
This shift is interrupted with a premature birth. Inappropriate IV therapy
can lead to persistent PDA, bronchopulmonary dysplasia, NEC, and intraventricular
hemorrhage. Insensible water losses are from lung (1/3) and skin (2/3).
Transepithelial (skin) water loss is the major component and decreases
with increase in postnatal age. Radiant warmers and phototherapy increase
insensible losses. Newborns produce a urine output of 2 cc/kg/hr to clear
the osmotic solute load at an osmolality of 250 mOsm/kg. Their kidney have
a low glomerular filtration rate and concentrating ability (limited urea
in medullary interstitium) and are therefore less tolerant to dehydration.
Electrolytes requirement of full-term: Na 2meq/kg/day, K 2 meq/kg/day at
a rate of fluid of 100cc/kg/24 hrs for the first 10 kg of weight.
References
1- Hellerstein S: Fluid and electrolytes: clinical aspects.
Pediatr Rev 14(3):103-15, 1993
2- Boineau FG, Lewy JE: Estimation of parenteral fluid
requirements. Pediatr Clin North Am 37(2):257-64, 1990
3- Statter MB: Fluids and electrolytes in infants and
children. Semin Pediatr Surg 1(3):208-11, 1992
4- Shaffer SG, Weismann DN: Fluid requirements in the
preterm infant. Clin Perinatol 19(1):233-50, 1992
5- De Bruin WJ, Greenwald BM, Notterman DA: Fluid resuscitation
in pediatrics. Crit Care Clin 8(2):423-38, 1992
6- Hammarlund K: Neonatal adaptation of fluid balance.
J Perinat Med 19 Suppl 1:80-5, 1991
Hepatoblastoma
Hepatoblastoma (HB) is the most common primary malignant neoplasm of the
liver in children mostly seen in males less than four year of age. Diagnostic
work-up (US, Scintigraphy, CT-Scan) objective is predicting resectability
and tumor extension. Diagnostic laparotomy will decide resectability. Markers
associated to this tumor are: alpha-fetoprotein and gamma-glutamyltransferase
II. Only reliable chances of cure is surgical excision although half are
unresectable at dx. Unresectable tumors can be managed with preop chemotx.
Disadvantages of preop chemotx are: progressive disease, increase morbidity,
post-op complications, and toxicity. Advantages are: decrease in tumor
size, covert three-fourth cases into resectable, although extent of surgery
is not decreased. Tumor necrosis is more extensive in pt. receiving preop
chemotx. Osteoid present in tumors after chemotx may represent an inherent
ability of the tumor to maturate and differentiate. Diploid tumors on DNA
flow cytometry show a better prognosis.
References
1- von Schweinitz D, Burger D, Mildenberger H: Is laparatomy
the first step in treatment of childhood liver tumors?--The experience
from the German Cooperative Pediatric Liver Tumor Study HB-89. Eur J Pediatr
Surg 4(2):82-6, 1994
2- Saxena R, Leake JL, Shafford EA, Davenport M, Mowat
AP, Pritchard J, Mieli-Vergani G, Howard ER, Spitz L, Malone M, et al:
Chemotherapy effects on hepatoblastoma. A histological study. Am J Surg
Pathol 17(12):1266-71, 1993
3- Conrad RJ, Gribbin D, Walker NI, Ong TH: Combined
cystic teratoma and hepatoblastoma of the liver. Cancer 72(10):2910-3,
1993
4- Tagge EP. Tagge DU. Reyes J. Tzakis A. Iwatsuki S.
Starzl TE. Wiener ES: Resection, including transplantation, for hepatoblastoma
and hepatocellular carcinoma: impact on survival. J Pediatr Surg 27(3):292-6,
1992; discussion 297
5- King DR, Ortega J, Campbell J, Haas J, Ablin A, Lloyd
D, Newman K, Quinn J, Krailo M, Feusner J, et al: The surgical management
of children with incompletely resected hepatic cancer is facilitated by
intensive chemotherapy. J Pediatr Surg 26(9):1074-80, 1991; discussion
1080-1
6- Gauthier F, Valayer J, Thai BL, Sinico M, Kalifa C:
Hepatoblastoma and hepatocarcinoma in children: analysis of a series of
29 cases. J Pediatr Surg 21(5):424-9, 1986
VOL 03 NO 05 NOVEMBER 1994
CVC Sepsis
Central Venous Catheter (CVC) placement has improved care and survival
of sick infants. Catheter sepsis with an incidence of 10-30% remains the
most common complication of CVC insertion. Defined as an apparent clinical
infection in a patient with a CVC proven by positive blood culture when
no other source can explain it. Principal isolated organism is coagulase-negative
staphylococci (CONS). These organisms are associated to foreign body placement
(V-P shunts, CVC, etc.) due to their adherents properties. Although contamination
of the catheter can occur during insertion or subsequent care, catheter
hub contamination is the primary site of entry of organism with secondary
colonization of the tip. The mechanism of infection is a poorly cleaned
entry site. Factors which increase the incidence CVC sepsis are: younger
age, primary diagnosis, use of TPN (lipid emulsions), multiple catheter
use, thrombus and fibrin sheath formation. Management of definite CVC sepsis
consists of antibiotics or removal. The use of urokinase and antibiotics
can effectively and safely manage these episodes leading to more than 90%
of infected catheter salvage. Persistent multiple organisms or fungal sepsis
will need catheter removal. A dilemma is to leave a possible infected or
remove a non-infected catheter. AOLC (Acridine-orange leucocyte cytospin)
test is specific and sensitive in rapidly (one hour) distinguishing catheter
septicemia when compared with NBT and CRP. Catheter care should include:
skin disinfection of catheter exit site with two 10-second application
of povidone swabs every 24 hour, and occlusion with a sterile semipermeable
dressing. Low-dose vancomycin added to TPN solutions has eliminated CONS-CVC
sepsis and increased useful catheter life. Staff training in caring for
CVC will reduce the incidence of CVC related-sepsis.
References
1- Tan TQ, Musser JM, Shulman RJ, Mason EO Jr, Mahoney
DH Jr, Kaplan SL: Molecular epidemiology of coagulase-negative Staphylococcus
blood isolates from neonates with persistent bacteremia and children
with central venous catheter infections. J Infect Dis 169(6):1393-7, 1994
2- Soong WJ, Hwang B: Percutaneous central venous catheterization:
five year experiment in a neonatal intensive care unit. Acta Paediatr Sin
34(5):356-66, 1993
3- Bansal V, Strauss A, Gyepes M,Kanchanapoom V: Central
line perforation associated with Staphylococcus epidermidis infection.
J Pediatr Surg 28(7):894-7, 1993
4- Malathi I, Millar MR, Leeming JP, Hedges A, Marlow
N: Skin disinfection in preterm infants. Arch Dis Child 69(3 Spec No):312-6,
1993
5- Rushforth JA, Hoy CM, Kite P, Puntis JW: Rapid diagnosis
of central venous catheter sepsis. Lancet 342(8868):402-3, 1993
6- Jones GR, Konsler GK, Dunaway RP, Lacey SR, Azizkhan
RG: Prospective analysis of urokinase in the treatment of catheter sepsis
in pediatric hematology-oncology patients. J Pediatr Surg 28(3):350-5,
1993; discussion 355-7
7- Salzman MB, Isenberg HD, Shapiro JF, Lipsitz PJ, Rubin
LG: A prospective study of the catheter hub as the portal of entry for
microorganisms causing catheter-related sepsis in neonates. J Infect Dis
167(2):487-90, 1993
8- Garland JS, Dunne WM Jr, Havens P, Hintermeyer M, Bozzette
MA, Wincek J, Bromberger T, Seavers M: Peripheral intravenous catheter
complications in critically ill children: a prospective study. Pediatrics
89(6 Pt 2):1145-50, 1992
9- Puntis JW, Holden CE, Smallman S, Finkel Y, George
RH, Booth IW: Staff training: a key factor in reducing intravascular catheter
sepsis. Arch Dis Child 66(3):335-7, 1991
Bezoars
Bezoars are rare foreign body concretions formed in the stomach and small
bowel composed mainly of hair (tricho), vegetable matter (phyto) or milk
curds (lacto). Most cases are females children, 6-10 years old, with bizarre
appetite (trichophagia) and emotional disturbances. Originally the mass
forms in the stomach and can move to the small bowel by fragmentation,
extension or total translocation. Diagnosis can be confirmed by UGIS, CT-Scan
or endoscopy. The child can develop an asymptomatic palpable abdominal
mass, pain, obstruction or perforation. Other children will reduce intake
and develop weight loss. Predisposing conditions to bezoar formations are:
gastric dymotility and decreased acidity. Management can consist of mechanical
or pulsating jet of water fragmentation via the endoscope, operative extraction,
shock-wave lithotripsy (ESWL) with subsequent evacuation, or dissolution
by oral ingestion of proteolytic enzymes (papain, acetylcysteine, cellulase).
With ESWL the shock wave pressure needed is less than half used for urolithiasis
cases.
References
1- Santiago-Sánchez C, Garau-Díaz
P,Lugo-Vicente HL: Trichobezoar in a 11-year old girl: A Case Report. Boletin
Asoc Med PR Vol 88 (1-3): 8-11, 1996
2- Sharma V, Sharma ID: Intestinal trichobezoar with perforation
in a child. J Pediatr Surg 27(4):518-9, 1992
3- Wadlington WB, Rose M, Holcomb GW Jr.: Complications
of trichobezoars: a 30-year experience. Southern Medical Journal.
85(10):1020-2, 1992
4- Rao PL, Mitra SK, Pathak IC: Trichobezoars in children.
International Surgery 66(1):63-5, 1981
5- Vergara Rodriguez J, Sarinana Natera C: Bezoars in
childhood. [Spanish] Boletin Medico Del Hospital Infantil De Mexico.
[JC:ag0] 34(6):1205-13, 1977
Cytokines
Cytokines (CK) are proteins produced by our own cells (macrophages, lymphocytes,
mast cells, fibroblasts, etc.) which modulate the acute phase of inflammation
after injury, infection and neoplastic growth. They play a key role in
control of hemopoiesis and immunity. Characterized so far: tumor necrosis
factor (TNF), interleukin (IL) 1 to 6, recently 8, and interferon. Recombinant
technologies have made them available. CK enhances neonatal myeloid progenitor
proliferation, modulates neonatal bone marrow neutrophil storage and proliferation
pools, induces peripheral neutrophilia and protects against the increase
mortality associated with bacterial sepsis. Early postoperative increases
in plasma IL-6 and IL-8 represent the stress response of neonates to surgery
with an exaggerated response during postop complications. IL-6 is responsible
for the acute phase response, and IL-8 with marked chemotactic property.
References
1- Chang M, Suen Y, Lee SM, Baly D, Buzby JS, Knoppel
E, Wolpe S, Cairo MS: Transforming growth factor-beta 1, macrophage inflammatory
protein-1 alpha, and interleukin-8 gene expression is lower in stimulated
human neonatal compared with adult mononuclear cells. Blood 84(1):118-24,
1994
2- Mathew P, Crist WM, Furman WL: The use of cytokines
in children. Curr Opin Pediatr 6(1):58-67, 1994
3- Hayward A, Cosyns M: Proliferative and cytokine responses
by human newborn T cells stimulated with staphylococcal enterotoxin B.
Pediatr Res 35(3):293-8, 1994
4- Wolf SS, Cohen A: Expression of cytokines and their
receptors by human thymocytes and thymic stromal cells. Immunology
77(3):362-8, 1992
5- Hettmannsperger U, Detmar M, Owsianowski M, Tenorio
S, Kammler HJ, Orfanos CE: Cytokine-stimulated human dermal microvascular
endothelial cells produce interleukin 6--inhibition by hydrocortisone,
dexamethasone, and calcitriol. J Invest Dermatol 99(5):531-6, 1992
6- Splawski JB, Lipsky PE: Cytokine regulation of immunoglobulin
secretion by neonatal lymphocytes. J Clin Invest 88(3):967-77, 1991
7- Parkman R: Cytokines and T lymphocytes in pediatrics.
J Pediatr 118(3):S21-3, 1991
VOL 03 NO 06 DECEMBER 1994
SCT
Sacrococcygeal teratoma (SCT) is the most common extragonadal germ cell
tumor in neonates with an incidence of one in 30-40,000 live births. Three-fourth
are females. SCT present as a large, firm or more commonly cystic masses
that arise from the anterior surface of the sacrum or coccyx, protruding
and forming a large external mass. Histology consist of tissue from the
three germ cell layers. SCT is classified as: mature, immature, or malignant
(endodermal sinus) and produces alpha-feto protein (AFP). Prenatal sonographic
diagnostic severity criteria are: tumor size greater than the biparietal
diameter of the fetus, rapid tumor growth, development of placentomegaly,
polyhydramnios and hydrops. Large tumors should benefit from cesarean section
to avoid dystocia or tumor rupture. Management consist of total tumor resection
with coccyx (recurrence is associated with leaving coccyx in place). Every
recurrence of SCT should be regarded as potentially malignant. Malignant
or immature SCT with elevated AFP after surgical resection will benefit
from adjuvant chemotherapy. Survival is 95% for mature/immature tumors,
but less than 80% for malignant cases. Follow-up should consist of (1)
meticulous physical exam every 3-6 months for first three years, (2) serial
AFP determination, (3) fecal/urodynamic functional studies. Long term F/U
has found a 40% incidence of fecal and urinary impairment associated to
either tumor compression of pelvic structures or surgical trauma.
References
1- Inoue M, Kubota A, Hasegawa T, Hata S, Takahashi
E, Kawahara H, Suehara N, Okada A: Antenatal diagnosis of sacrococcygeal
teratoma with hydrops fetalis; a case report. Eur J Pediatr Surg 4(2):125-7,
1994
2- Evans MJ, Danielian PJ, Gray ES: Sacrococcygeal
teratoma: a case of mistaken identity. Pediatr Radiol 24(1):52-3, 1994
3- Teitelbaum D, Teich S, Cassidy S, Karp M, Cooney D,
Besner G: Highly vascularized sacrococcygeal teratoma: description of this
atypical variant and its operative management. J Pediatr Surg 29(1):98-101,
1994
4- Rintala R, Lahdenne P, Lindahl H, Siimes M, Heikinheimo
M:Anorectal function in adults operated for a benign sacrococcygeal teratoma.
J Pediatr Surg 28(9):1165-7, 1993
5- Bilik R. Shandling B. Pope M.Thorner P. Weitzman S.
Ein SH: Malignant benign neonatal sacrococcygeal teratoma. J Pediatr Surg
28(9):1158-60, 1993
6- Liu KK. Lee KH. Ku KW: Sacrococcygeal teratoma in children:
a diagnostic challenge. Aust N Z J Surg 64(2):102-5, 1994
7- Boemers TM, van Gool JD, de Jong TP, Bax KM: Lower
urinary tract dysfunction in children with benign sacrococcygeal teratoma.
J Urol 151(1):174-6, 1994
8- Schropp KP
AU - Lobe TE, Rao B, Mutabagani K, Kay GA, Gilchrist
BF, Philippe PG, Boles ET Jr: Sacrococcygeal teratoma: the experience of
four decades. J Pediatr Surg 27(8):1075-8, 1992; discussion 1078-9
Grave's
Hyperthyroidism in children is caused by a non-immune autonomous adenoma
(rare), hyperfunctional nodular goiter (less frequent), or more commonly
diffuse immunogenic gland enlargement (Grave's Disease). Grave's children
manifest initial neurologic symptoms and tachycardia. Management consist
of: (1) medical- antithyroid drugs, hormone substitution, and iodine therapy,
(2) surgical excision, or (3) radio-iodine therapy (not routine used due
to possible induction of malignancy). After two years of antithyroid drug
therapy hyperthyroidism recurs in 40-70% of cases. The only factor predicting
remission with drug tx is absence of ophthalmopathy. Main disadvantages
of antithyroid drugs are the need for prolonged treatment and risk of recurrence.
Indications for surgery are: poor compliance with drug tx, recurrent hyperthyroidism
after prolonged (two years) drug tx, side effects to drugs (neutropenia,
vasculitis, etc.), a cosmetically unpleasant or obstructive symptomatic
goiter. Before surgical therapy clinical and biochemical euthyroidism should
be obtained. Extent of resection is debatable and depends on: surgical
expertise, extent of recurrent hyperthyroidism (8-12% incidence), and rate
of hypothyroidism complications. Most prefer subtotal thyroidectomy (retaining
6-10 GM of tissue), other total gland removal. Surgical complications are:
recurrent nerve paralysis, temporary or permanent hypoparathyroidism, and
post-op thyrotoxic crisis. Ophthalmopathy is less severe and disappears
when euthyroidism is obtained. Lymphocytic infiltration if found in three-fourths
of glands removed.
References
1- Mariotti S, Caturegli P, Barbesino G, Ceccarelli C,
Lippi F, Marino M, Manetti L, Martino E,Pinchera A: [Radiometabolic therapy
of the autonomous thyroid nodule] Minerva Endocrinol 18(4):155-63, 1993
2- Rajasoorya C: Examining the therapeutic options in
hyperthyroidism--a personal perspective.Ann Acad Med Singapore 22(4):617-23,
1993
3- Sills IN, Horlick MN, Rapaport R: Inappropriate suppression
of thyrotropin during medical treatment of Graves disease in childhood.
J Pediatr 121(2):206-9, 1992
4- Csaky G, Balazs G, Bako G, Ilyes I, Kalman K, Szabo
J: Late results of thyroid surgery for hyperthyroidism performed in childhood.
Prog Pediatr Surg 26:31-40, 1991
5- Rauh V, Kujath HP, Reimers C, Hocht B: Indications,
surgical treatment and after-care in juvenile hyperthyroidism. Prog Pediatr
Surg 26:28-30, 1991
6- Ladurner D, Riccabona G: Surgical aspects of diseases
of the thyroid gland in childhood. Prog Pediatr Surg 26:15-20, 1991
LH-RH
Gonadotropin releasing hormone (LH-RH) is a decapeptide that when used
as nasal spray will cause descend of one-third of unilateral palpable undescended
testis, effect potentiated with the subsequent use of Human Chorionic Gonadotropin.
Treatment is more effective the younger the age of the boys and the near
is the testis to the scrotum. LH-RH is recommended as initial therapy of
testicular non-descent because is non-invasive, has good response in younger
age groups, and limited side-effects. The number of germ cells per tubule
(fertility index) increases in patient who responds to LH-RH. Contraindications
for hormonal therapy are: (1) coexistent inguinal hernia or hydrocele testis,
and (2) previous inguinal operation. High non-palpable testis have poor
response to hormonal therapy.
References
1- Christiansen P, Muller JR, Buhl SB, Hansen OR, Hobolth
N, Jacobsen BB, Jorgensen PI, Kastrup KW, Nielsen K, Nielsen LB, et al:[Cryptorchism.
Treatment with human chorionic gonadotropin or gonadotropin-releasing hormone?]
Ugeskr Laeger 155(41):3287-90, 1993
2- Thorup J, Cortes D, Nielsen OH: Clinical and histopathological
evaluation of operated maldescended testes after LH-RH treatment. Eur J
Pediatr 152 Suppl 2:S37, 1993
3- Waldschmidt J, Doede T, Vygen I: The results of 9 years
of experience with a combined treatment with LH-RH and HCG for cryptorchidism.Eur
J Pediatr 152 Suppl 2:S34-6, 1993
4- Frick J: LHRH and cryptorchidism. Eur J Pediatr
152 Suppl 2:S28-30, 1993
5- Christiansen P, Muller J, Buhl S, Hansen OR, Hobolth
N, Jacobsen BB, Jorgensen PH, Kastrup KW, Nielsen K, Nielsen LB, et al:
Hormonal treatment of cryptorchidism--hCG or GnRH--a multicentre
study. Acta Paediatr 81(8):605-8, 1992